NCT05166161 A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04879277 Study of Low-grade Systemic Inflammation in Adult Patients With Phenylketonuria Status COMPLETED Phase NA
NCT04534842 Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria Status COMPLETED Phase PHASE2
NCT04348708 Long-Term Follow Up Study of Subjects Previously Administered HMI 102 Status ENROLLING_BY_INVITATION Phase N/A
NCT04085666 Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of CDX-6114 in Patients With Phenylketonuria (PKU) Status COMPLETED Phase PHASE1
NCT03516487 Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria Status COMPLETED Phase PHASE1/PHASE2
NCT03097250 MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria Status COMPLETED Phase N/A
NCT02468570 A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302 Status COMPLETED Phase N/A
NCT02297347 The Brain and Neuropsychological Functioning in Adults With Sapropterin Dihydrochloride Treated Phenylketonuria Status COMPLETED Phase N/A
NCT02176603 Observational Study of Endothelial Dysfunction in Phenylketonuria Status COMPLETED Phase N/A
NCT01977820 Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria Status TERMINATED Phase PHASE2